Trial
NCT00517491
Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG)
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Ipsen
Collaborators
—
Condition
Acromegaly
Intervention
lanreotide (Autogel formulation)
Why stopped
Administrative reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-08-05